Company Profile
Apeloa Pharmaceutical provides raw materials various pharmaceutical factories in the People's Republic of China and globally. Its operations are structured into API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series.
Its portfolio also includes innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and commercial projects, and pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories
Technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification
Controlled-release formulation development, taste masking technology, and particle flow simulation. Additionally, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and brands. Founded in 1989, Apeloa Pharmaceutical is based in Dongyang, the People's Republic of China.